Fidelity SPDR Advertisement
Home > Boards > Free Zone > User's Groups > WEALTH UNIVERSITY

Tomorrow's bio-tech bluechip....only good for long 6 months

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whatisthecolorofmone Member Profile
 
Followed By 80
Posts 6,321
Boards Moderated 0
Alias Born 09/16/10
160x600 placeholder
Target again lowered its earnings outlook for the year, still reeling from data breach of its customers' credit and debit card information and slower traffic at its stores. Target also posted a 62% decline in 2Q earnings. Shares fell 1% premarket.
More Top Equities Stories Of The Day
Berkshire Hathaway Continued Investing in Media in 2Q
Skilled HealthCare, Genesis HealthCare to Merge
Tech Stocks Weaken Ahead Of H-P's Earnings
Infineon to Buy International Rectifier for $3 Billion -- 4th Update
Steve Ballmer Steps Down From Microsoft Board -- Update
U.S. Hot Stocks: Hot Stocks to Watch
Alaska Oil Tax Repeal Measure Losing--Update
Supervalu Investigating Potential Data Breach
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist